by Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering gastrointestinal oncologist Dr. James Harding. Credit: Memorial Sloan Kettering Cancer Center Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely to cause...
by Brigham and Women’s Hospital Credit: Unsplash/CC0 Public Domain A pilot trial by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and...
by Krista Conger, Stanford University Medical Center Graphical abstract. Credit: Cell Stem Cell (2022). DOI: 10.1016/j.stem.2022.10.009 Muscle stem cells, the cells in muscle fibers that generate new muscle cells after injury or exercise, lose their potency with age. But a study by researchers at Stanford Medicine shows that old mice regain the leg muscle strength of younger...
by Carla K. Johnson This 2014 photo made available by the U.S. Centers for Disease Control and Prevention shows a feeding female Anopheles funestus mosquito. The species is a known vector for malaria. The parasitic disease killed more than 620,000 people in 2020 and caused 241 million cases, mainly in children under 5 in Africa....
by AIDS Clinical Trials Group Credit: Unsplash/CC0 Public Domain The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded to conduct research into COVID-19, today announced the publication of “Monoclonal Antibody Treatment Drives Rapid Culture Conversion in SARS-CoV-2 Infection,” in the journal Cell Reports Medicine. The publication reports on findings from the...
Only one currently authorized antibody treatment retains its activity against all omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong. The study also shows that the effectiveness of mRNA vaccines is reduced against all three subvariants of omicron. The findings were published in Nature(link is external and opens in...
